Jatenzo is not currently available in China. Regulatory approvals and market launch timelines dictate drug availability in different regions [1].
When might Jatenzo become available in China?
Specific timelines for Jatenzo's potential availability in China are not publicly disclosed. Drug introductions to new markets depend on a company's global strategy, regulatory submission timelines, and the success of clinical trials and approvals by the relevant health authorities, such as China's National Medical Products Administration (NMPA) [1].
What is Jatenzo?
Jatenzo (testosterone) is an oral formulation of testosterone indicated for men with low testosterone due to certain medical conditions [2]. It is a prodrug that is converted in the body to testosterone [3].
What is the difference between Jatenzo and other testosterone treatments?
Jatenzo is an oral testosterone replacement therapy [2]. Many other testosterone treatments are administered through injections, gels, patches, or pellets, offering different delivery methods and pharmacokinetic profiles [4].
Who makes Jatenzo?
Jatenzo is developed and marketed by Besse Medical, a subsidiary of Acarda [5].
What are the regulatory hurdles for a drug like Jatenzo in China?
Introducing a new drug like Jatenzo into the Chinese market involves navigating complex regulatory processes. This typically includes preclinical testing, Phase I, II, and III clinical trials conducted within China or with data accepted by the NMPA, followed by submission of a comprehensive dossier for review and approval [6]. The NMPA has specific guidelines for the approval of pharmaceuticals, which may include requirements for local clinical data [7].
Where is Jatenzo currently available?
Jatenzo is currently approved and available in the United States [2].
Are there any patents related to Jatenzo that might affect its availability?
Patent protection is a key factor in drug development and market exclusivity. Information regarding Jatenzo's patent status and expiration dates in various regions can be found through resources like DrugPatentWatch.com [8]. Patents can influence when generic versions of a drug might become available, impacting market dynamics and pricing, though this is more relevant to markets where the drug is already approved.
What are the potential challenges for oral testosterone therapy in China?
While not specific to Jatenzo's availability, general challenges for new drug introductions in China can include meeting local clinical trial requirements, understanding the reimbursement landscape, and competition from existing therapies. The preference for certain administration routes can also vary by market [6].
---
1. Besse Medical. (n.d.). Global Presence. Retrieved from https://www.bessemedical.com/global-presence/
2. Jatenzo. (n.d.). About Jatenzo. Retrieved from https://www.jatenzo.com/
3. Besse Medical. (n.d.). Jatenzo: How it Works. Retrieved from https://www.jatenzo.com/how-it-works
4. WebMD. (n.d.). Testosterone Therapy. Retrieved from https://www.webmd.com/men/testosterone-therapy
5. Besse Medical. (n.d.). About Us. Retrieved from https://www.bessemedical.com/about-us/
6. National Medical Products Administration (NMPA). (n.d.). Pharmaceuticals. Retrieved from http://www.nmpa.gov.cn/
7. Deloitte. (2023). China Life Sciences Outlook 2023. Retrieved from https://www2.deloitte.com/
8. DrugPatentWatch.com. (n.d.). Jatenzo Patent Information. Retrieved from https://drugpatentwatch.com/